Literature DB >> 27830409

Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

Robert J Donovan1, Calvin Choi2, Asghar Ali3, Douglas M Heuman1, Michael Fuchs1, Anthony A Bavry2, Ion S Jovin1.   

Abstract

Patients with advanced liver disease have a high prevalence of cardiovascular risk factors, but many of them are asymptomatic. Cardiovascular risk stratification prior to liver transplant can be done by dobutamine stress echocardiography, stress myocardial perfusion imaging, cardiac computer tomography, and coronary angiography, but there are no clear recommendations regarding what method should be used and who should be screened. Because of this and because of inherent risk profile in this population, the variations in practice are significant. Careful screening and rigorous management of cardiovascular risk factors are important to ensure optimal cardiovascular outcomes in the immediate post-transplantation period and in the long term as well.

Entities:  

Keywords:  Cardiovascular risk; Coronary artery disease; End-stage liver disease; Liver transplantation

Mesh:

Year:  2016        PMID: 27830409     DOI: 10.1007/s10620-016-4371-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  63 in total

Review 1.  Assessment of intermediate severity coronary lesions in the catheterization laboratory.

Authors:  Jonathan Tobis; Babak Azarbal; Leo Slavin
Journal:  J Am Coll Cardiol       Date:  2007-02-09       Impact factor: 24.094

2.  Role of baseline echocardiography in the preoperative management of liver transplant candidates.

Authors:  Matthew E Harinstein; Sunil Iyer; Michael A Mathier; James D Flaherty; Paulo Fontes; Raymond M Planinsic; Kathy Edelman; William E Katz; Angel Lopez-Candales
Journal:  Am J Cardiol       Date:  2012-09-25       Impact factor: 2.778

3.  Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management.

Authors:  Stephen H Caldwell; Maureane Hoffman; Ton Lisman; B Gail Macik; Patrick G Northup; K Rajender Reddy; Armando Tripodi; Arun J Sanyal
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

4.  Cardiovascular complications following liver transplantation.

Authors:  G W Dec; N Kondo; M L Farrell; J Dienstag; A B Cosimi; M J Semigran
Journal:  Clin Transplant       Date:  1995-12       Impact factor: 2.863

5.  Microvascular autonomic dysfunction may justify false-positive stress myocardial perfusion imaging in patients with liver cirrhosis undergoing liver transplantation.

Authors:  M Senzolo; M Bassanello; A Graziotto; P Zucchetta; U Cillo; G Maraglino; M Loreno; F Bellotto; G Davià; P Burra
Journal:  Transplant Proc       Date:  2008 Jul-Aug       Impact factor: 1.066

6.  Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years.

Authors:  Javier F Aduen; Bangarulingam Sujay; Rolland C Dickson; Michael G Heckman; Winston R Hewitt; Wolf H Stapelfeldt; Jeffrey L Steers; Denise M Harnois; David J Kramer
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

7.  Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma.

Authors:  Scott W Biggins; Kiran M Bambha; Norah A Terrault; John Inadomi; Stephen Shiboski; Jennifer L Dodge; Jane Gralla; Hugo R Rosen; John P Roberts
Journal:  Liver Transpl       Date:  2012-12       Impact factor: 5.799

8.  Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.

Authors:  Fawaz Almutairi; Theresa C Peterson; Michele Molinari; Mark J Walsh; Ian Alwayn; Kevork M Peltekian
Journal:  Liver Transpl       Date:  2009-05       Impact factor: 5.799

9.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

10.  Influence of coronary artery disease on outcomes after liver transplantation.

Authors:  D A Diedrich; J Y Findlay; B A Harrison; C B Rosen
Journal:  Transplant Proc       Date:  2008-12       Impact factor: 1.066

View more
  2 in total

Review 1.  CON: Patients of Advanced Age Should Not Routinely Undergo Liver Transplantation.

Authors:  Avash Kalra; Michael Kriss; Prashanth Francis; J P Norvell
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-09-02

2.  Living Donor Liver Transplant in Patients Aged 60 Years or Older: Experience from a Large Volume Centre in India.

Authors:  Ravindra Nidoni; Rajasekhar Kandagaddala; Shaleen Agarwal; Rajesh Dey; Bhargava R Chikkala; Subhash Gupta
Journal:  J Clin Exp Hepatol       Date:  2020-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.